These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38523135)

  • 1. Letter: Thioguanine, an under-utilised option in inflammatory bowel disease? Authors' reply.
    Vasudevan A; Con D; van Langenberg DR
    Aliment Pharmacol Ther; 2024 Apr; 59(8):1011. PubMed ID: 38523135
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: Thioguanine, an underutilised option in inflammatory bowel disease?
    Chetwood JD; Paramsothy S; Leong RW
    Aliment Pharmacol Ther; 2024 Apr; 59(8):1009-1010. PubMed ID: 38523080
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter: thiopurine blood monitoring for patients with inflammatory bowel disease.
    El-Matary W
    Aliment Pharmacol Ther; 2012 Mar; 35(6):742; author reply 743-4. PubMed ID: 22348522
    [No Abstract]   [Full Text] [Related]  

  • 4. Letter: TPMT activity and age in IBD patients.
    Stocco G; De Iudicibus S; Cuzzoni E; Decorti G; Martelossi S; Ventura A
    Aliment Pharmacol Ther; 2012 Apr; 35(8):966-7; author reply 967-9. PubMed ID: 22436044
    [No Abstract]   [Full Text] [Related]  

  • 5. Thioguanine Therapy in Inflammatory Bowel Diseases. A Practical Guide.
    Crouwel F; Simsek M; Mulder CJ; Buiter HJ; De Boer NK
    J Gastrointestin Liver Dis; 2020 Dec; 29(4):637-645. PubMed ID: 33331335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing treatment with thioguanine derivatives in inflammatory bowel disease.
    Louis E; Belaiche J
    Best Pract Res Clin Gastroenterol; 2003 Feb; 17(1):37-46. PubMed ID: 12617881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 6-Thioguanine can cause serious liver injury in inflammatory bowel disease patients.
    Walker TR; Leichter AM
    J Pediatr Gastroenterol Nutr; 2004 Feb; 38(2):232-3. PubMed ID: 14974466
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of thioguanine treatment in inflammatory bowel disease: A systematic review.
    Meijer B; Mulder CJ; Peters GJ; van Bodegraven AA; de Boer NK
    World J Gastroenterol; 2016 Oct; 22(40):9012-9021. PubMed ID: 27833392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 6-Thioguanine-related hepatotoxicity in patients with inflammatory bowel disease: dose or level dependent?
    Derijks LJ; Gilissen LP; de Boer NK; Mulder CJ
    J Hepatol; 2006 Apr; 44(4):821-2. PubMed ID: 16487623
    [No Abstract]   [Full Text] [Related]  

  • 10. 6-thioguanine-buried alive?
    Herrlinger KR; Schwab M; Fellermann K; Stange EF
    Gastroenterology; 2004 Mar; 126(3):940-1; author reply 941-2. PubMed ID: 14988863
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and safety of 6-thioguanine in the management of inflammatory bowel disease.
    Qasim A; McDonald S; Sebastian S; McLoughlin R; Buckley M; O'Connor H; O'Morain C
    Scand J Gastroenterol; 2007 Feb; 42(2):194-9. PubMed ID: 17327939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic drug monitoring of 6-thioguanine nucleotides in inflammatory bowel disease: interest and limits].
    Jourdil N; Fonrose X; Boulieu R; Stanke-Labesque F;
    Therapie; 2010; 65(3):177-86. PubMed ID: 20699068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reply to: Therapeutic Drug Monitoring for IBD Children on Thioguanine.
    Bayoumy AB; Jagt JZ; de Boer NKH; de Meij TGJ
    J Pediatr Gastroenterol Nutr; 2023 Sep; 77(3):e65-e66. PubMed ID: 37346010
    [No Abstract]   [Full Text] [Related]  

  • 14. Thiopurines in Inflammatory Bowel Disease: New Findings and Perspectives.
    de Boer NKH; Peyrin-Biroulet L; Jharap B; Sanderson JD; Meijer B; Atreya I; Barclay ML; Colombel JF; Lopez A; Beaugerie L; Marinaki AM; van Bodegraven AA; Neurath MF
    J Crohns Colitis; 2018 Apr; 12(5):610-620. PubMed ID: 29293971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy of chronic inflammatory bowel diseases with azathioprine, 6-mercaptopurine and 6-thioguanine. Clinico-pharmacologic aspects].
    Schwab M; Herrlinger K; Schaeffeler E; Stange EF
    Dtsch Med Wochenschr; 2003 Feb; 128(8):378-85. PubMed ID: 12594624
    [No Abstract]   [Full Text] [Related]  

  • 16. A Systematic Review and Meta-Analysis of 6-Thioguanine Nucleotide Levels and Clinical Remission in Inflammatory Bowel Disease.
    Estevinho MM; Afonso J; Rosa I; Lago P; Trindade E; Correia L; Dias CC; Magro F;
    J Crohns Colitis; 2017 Oct; 11(11):1381-1392. PubMed ID: 28981590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thiopurines in inflammatory bowel disease: new strategies for optimization of pharmacotherapy?
    Derijks LJ; Hommes DW
    Curr Gastroenterol Rep; 2006 Apr; 8(2):89-92. PubMed ID: 16533469
    [No Abstract]   [Full Text] [Related]  

  • 18. [Continued development of drugs: the path of thioguanine].
    Simsek M; de Boer NKH; Mulder CJJ
    Ned Tijdschr Geneeskd; 2018; 162():D1757. PubMed ID: 29350120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why measure thiopurine methyltransferase activity? Direct administration of 6-thioguanine might be the alternative for 6-mercaptopurine or azathioprine.
    de Jong D; Mulder CJ; van Sorge AA
    Gut; 2001 Dec; 49(6):874. PubMed ID: 11758505
    [No Abstract]   [Full Text] [Related]  

  • 20. 6-TG for IBD. simple, but safe?
    Tremaine WJ
    Am J Gastroenterol; 2003 May; 98(5):950-2. PubMed ID: 12809812
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.